Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Down 2.4%

Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPFGet Free Report) were down 2.4% during trading on Thursday . The company traded as low as $2.40 and last traded at $2.49. Approximately 588,151 shares changed hands during trading, an increase of 777% from the average daily volume of 67,097 shares. The stock had previously closed at $2.55.

Cardiol Therapeutics Stock Performance

The stock’s 50 day simple moving average is $2.06 and its 200 day simple moving average is $1.49.

About Cardiol Therapeutics

(Get Free Report)

Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.

Recommended Stories

Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.